[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_1190 

# __Efficacy against coronavirus__

## Name of the Benefit

Continuously active antimicrobial coating shows efficacy against coronavirus, reducing its spread

## Description of actual returns pertaining to this benefit

* [Reduced business disruptions, improved public health, increased asset value through reputation and tenant retention](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1329.md)

## Articles mentionning this Benefit

* [A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_246.md)

## Stakeholders benefitting from this Benefit

* [Residents](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_59.md)
* [Healthcare facilities](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_33.md)
* [Commercial facilities](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_466.md)

## Risks which can benefit from this action

* [Continuously active antimicrobial coating](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1189.md)

